Excess weight risk factor for alcoholic liver disease

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Hepatology

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/HEP.510250120PMID 8985274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alcohol and the liver: 1994 update.

  1994cited by this paper
• Epidemiology of alcoholic liver disease.

  1993cited by this paper
• Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P450 (CYP2E1) in the liver of rats chronically fed ethanol.

  1992cited by this paper
• Effect of dietary fat on Ito cell activation by chronic ethanol intake: a long-term serial morphometric study on alcohol-fed and control rats.

  1991cited by this paper
• A simple biological index for detection of alcoholic liver disease in drinkers.

  1991cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Diet and alcohol in liver cirrhosis: a case-control study.

  1990cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Beef fat prevents alcoholic liver disease in the rat.

  1989cited by this paper
• Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

  1988cited by this paper
• Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics.

  1988cited by this paper
• Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury.

  1988cited by this paper
• Quetelet's index (W/H2) as a measure of fatness.

  1985cited by this paper
• [Epidemiology and risks of obesity].

  1984cited by this paper
• Clinicopathological study of alcoholic fibrosis.

  1982cited by this paper
• New norms of upper limb fat and muscle areas for assessment of nutritional status.

  1981cited by this paper
• Sex-related differences among 100 patients with alcoholic liver disease.

  1977cited by this paper
• Alcohol and the Liver

  1977cited by this paper
• [Feasibility survey on the reliability of questionning on past eating habits in a group of men (author's transl)].

  1976cited by this paper
• Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscle and endothelial cells.

  1974cited by this paper

• The Impact of Metabolic Dysfunction and Bariatric Surgery on Severity and Outcomes in Alcohol Associated Hepatitis.

  2025cites this paper
• De NAFLD a MAFLD para llegar a MASLD: La nueva nomenclatura de esteatosis hepática metabólica

  2025cites this paper
• Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary

  2025cites this paper
• Cold atmospheric plasma control metabolic syndromes via targeting fat mass and obesity-associated protein.

  2025cites this paper
• Association between insulin and liver function tests, liver disease and cirrhosis in population-based cohorts with long term follow-up

  2025cites this paper
• Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD

  2025cites this paper
• Liver transplantation for alcohol-associated liver disease: The changing landscape

  2025cites this paper
• MetALD: Genetic Factors and Clinical Outcomes

  2025cites this paper
• Diagnosis and Management of Early Stages of ALD

  2025cites this paper
• Liver Failure from Alcohol Takes on Several Forms: Decompensated Cirrhosis, Acute-on-Chronic Liver Failure, and Alcohol-Related Hepatitis.

  2025cites this paper
• Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease.

  2025cites this paper
• Global Burden of Alcohol‐Associated Liver Disease Across 204 Countries, 1990–2021: GBD 2021 Findings

  2025cites this paper
• LINC01018 attenuates hepatic lipid accumulation by inducing autophagy via DHX9 pathway in alcohol-associated liver disease.

  2025cites this paper
• Chronic Alcohol and Liver Health: The Gut-Liver Axis as a Therapeutic Target

  2025cites this paper
• Alcohol-Related Liver Disease: Spectrum of Disease, Natural History, and Outcomes.

  2025cites this paper
• Alcohol-related liver disease

  2025cites this paper
• Incidence Trends and Risk Factors of Alcohol-Specific Deaths

  2024cites this paper
• MetALD: Clinical aspects, pathophysiology and treatment

  2024cites this paper
• Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease

  2024cites this paper
• EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

  2024cites this paper
• Liver fibrosis screening increases alcohol abstinence

  2024cites this paper
• Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective

  2024cites this paper
• Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis

  2024cites this paper
• Cirrhose métabolique : une entité en plein essor

  2024cites this paper
• Épidémiologie et facteurs de risque de la maladie du foie liée à l’alcool

  2024cites this paper
• Prognostic value of relative adrenal insufficiency in patients with severe alcohol-associated hepatitis-a prospective clinical study.

  2024cites this paper
• Hemorragia de vías digestivas altas analizadas en pacientes con cirrosis hepática alcohólica en Boyacá (Colombia)

  2024cites this paper
• Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score

  2024cites this paper
• S2k-Leitlinie Klinische Ernährung in der Hepatologie

  2024cites this paper
• EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  2024cites this paper
• Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury

  2024cites this paper
• Modest effect of differential dietary vitamin A intake on the pathogenesis of alcohol-associated liver disease.

  2024cites this paper
• Flavonoids-based nanomedicine for the treatment of liver fibrosis: A recent progress

  2024cites this paper
• Severe Alcoholic Hepatitis-optimizing Medical Management: Whether we need a Liver Transplant

  2024cites this paper
• Alcohol-associated liver disease: Natural history, management and novel targeted therapies

  2024cites this paper
• Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use

  2024cites this paper
• Immunology and treatments of fatty liver disease

  2024cites this paper
• Non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography

  2023cites this paper
• Nutritional Support for Alcoholic Liver Disease

  2023cites this paper
• Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

  2023cites this paper
• Alcohol-related hepatitis: A review article

  2023cites this paper
• The Impact of Metabolic Syndrome on the Prognosis of High-Risk Alcoholic Hepatitis Patients: Redefining Alcoholic Hepatitis

  2023cites this paper
• Defining recompensation of alcohol‐related liver disease: A step beyond decompensated cirrhosis

  2023cites this paper
• Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease.

  2023cites this paper
• Loss of SQSTM1/p62 Induces Obesity and Exacerbates Alcohol-Induced Liver Injury in Aged Mice

  2023cites this paper
• mTORC1 inhibition uncouples lipolysis and thermogenesis in white adipose tissue to contribute to alcoholic liver disease

  2023cites this paper
• Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease

  2023cites this paper
• Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease

  2023cites this paper
• A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis

  2023cites this paper
• Difusión de nueva nomenclatura en esteatosis hepática

  2023cites this paper
• Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use

  2023cites this paper
• Alcohol-associated liver disease: epidemiology and management.

  2023cites this paper
• The Origin and Fate of Liver Myofibroblasts

  2023cites this paper
• A clinical case of fatty liver disease. How the new nomenclature can be applied in practice

  2023cites this paper
• Sex differences in chronic liver disease and benign liver lesions

  2023cites this paper
• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  2023cites this paper
• Hépatite alcoolique sévère

  2023cites this paper
• Humulus japonicus Extract Ameliorates Hepatic Steatosis Through the PPARα-Mediated Suppression of Alcohol-Induced Oxidative Stress

  2023cites this paper
• The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

  2023cites this paper
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

  2023cites this paper
• Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

  2023cites this paper
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

  2023cites this paper
• Management of alcoholic hepatitis: A clinical perspective

  2023cites this paper
• Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis

  2023cites this paper
• Алкогольна хвороба печінки

  2023cites this paper
• Management of alcohol use disorder in patients with chronic liver disease

  2023cites this paper
• The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors

  2022cites this paper
• RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease

  2022cites this paper
• Emerging Biomarkers in Alcohol-associated Hepatitis.

  2022cites this paper
• Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma

  2022cites this paper
• Trends of Readmissions for Gastrointestinal Bleeding After Alcoholic Hepatitis: Analysis of the Nationwide Readmission Database

  2022cites this paper
• Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?

  2022cites this paper
• Ten-year trends and prediction model of 30-day inpatient mortality for alcoholic hepatitis in the United States

  2022cites this paper
• Women and liver: Is woman the future of man?

  2022cites this paper
• Alcohol use disorder in community management of chronic liver diseases

  2022cites this paper
• Epidemiology and Disease Burden of Alcohol Associated Liver Disease.

  2022cites this paper
• Alcohol-Related Elevation of Liver Transaminase Is Associated With Gut Microbiota in Male

  2022cites this paper
• Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis

  2022cites this paper
• Periplaneta americana extract alleviates steatohepatitis in a mouse model by modulating HMGB1-mediated inflammatory response

  2022cites this paper
• Breakthroughs in therapies for NASH and remaining challenges.

  2022cites this paper
• Genetic and Environmental Susceptibility to Alcoholic Hepatitis.

  2021influential citation
• Current and Future Biomarkers in Alcoholic Hepatitis.

  2021cites this paper
• Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality

  2021cites this paper
• Serum HMGB1 Associates with Liver Disease and Predicts Readmission and Mortality in Patients with Alcohol Use Disorder.

  2021cites this paper
• Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study

  2021cites this paper
• Sex Differences in Alcohol Consumption and Alcohol-Associated Liver Disease.

  2021cites this paper
• Alcohol and Metabolic-associated Fatty Liver Disease

  2021cites this paper
• A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis

  2021cites this paper
• IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY.

  2021cites this paper
• Experimental models of metabolic and alcoholic fatty liver disease

  2021cites this paper
• Hepatoprotective Effect of Trehalose: Insight into Its Mechanisms of Action.

  2021cites this paper
• The rates of middle molecules in the blood in rats with different motor activity in alcoholic and non alcoholic exerimental hepatosis

  2021cites this paper
• Effect of physician-prescribed nalmefene on alcohol intake reduction in patients with alcohol-related liver disease

  2021cites this paper
• Deficiency of Cathelicidin Attenuates High-Fat Diet Plus Alcohol-Induced Liver Injury through FGF21/Adiponectin Regulation

  2021cites this paper
• An algorithm for the management of non-alcoholic fatty liver disease in primary care

  2021cites this paper
• A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease.

  2021cites this paper
• CONCEPÇÕES DE ESTUDANTES BRASILEIROS DE ENSINO MÉDIO SOBRE BEBIDAS ALCOÓLICAS

  2021cites this paper
• Effect of Body Mass Index on the Prognosis of Liver Cirrhosis

  2021cites this paper
• Effect of an extract of Pinus koraiensis leaves, Lycium chinense fruit, and Saururus chinensis (Lour.) Baill. leaves on liver function in excessive drinkers: A randomized, double-blind, placebo-controlled trial

  2021cites this paper
• Combined alcoholic and non-alcoholic steatohepatitis

  2020cites this paper